Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / Ordinary Shares, nominal value EURO0.003 per share, represented by American Depository Shares
-
Shares outstanding
-
791M
-
Number of holders
-
12
-
Total 13F shares, excl. options
-
1.76M
-
Shares change
-
-31K
-
Total reported value, excl. options
-
$5.13M
-
Value change
-
-$79.4K
-
Number of buys
-
5
-
Number of sells
-
-6
-
Price
-
$2.94
Significant Holders of Mereo BioPharma Group plc - Ordinary Shares, nominal value EURO0.003 per share, represented by American Depository Shares (MREO) as of Q3 2019
15 filings reported holding MREO - Mereo BioPharma Group plc - Ordinary Shares, nominal value EURO0.003 per share, represented by American Depository Shares as of Q3 2019.
Mereo BioPharma Group plc - Ordinary Shares, nominal value EURO0.003 per share, represented by American Depository Shares (MREO) has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.76M shares
of 791M outstanding shares and own 0.22% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (683K shares), BVF INC/IL (523K shares), PERCEPTIVE ADVISORS LLC (179K shares), RENAISSANCE TECHNOLOGIES LLC (166K shares), CSS LLC/IL (78.2K shares), Birchview Capital, LP (77.6K shares), STATE STREET CORP (16.5K shares), BRIDGEWAY CAPITAL MANAGEMENT INC (16K shares), BANK OF AMERICA CORP /DE/ (12.1K shares), and Tower Research Capital LLC (TRC) (1.74K shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.